Chronic Lower Back Pain Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Non-steroidal Anti-Inflammatory Drugs, Antidepressants, Analgesic, Opioids, and Others), By Route of Administration (Oral, Topical, and Others), By Distribution Channel (Hospital Pharmacies and Retail & Online Pharmacies), and Regional Forecast, 2025-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 10.1% from 2025 to 2032

Unit

Value (USD billion)

Segmentation

By Drug Class

• Non-steroidal Anti-Inflammatory Drugs
• Antidepressants
• Analgesic
• Opioids
• Others

By Route of Administration

• Oral
• Topical
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail & Online Pharmacies

By Region

• North America (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region)
  • U.S.
  • Canada
• Europe (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region)
  • China
  • India
  • Japan
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa